See more : Wins Finance Holdings Inc. (WINSF) Income Statement Analysis – Financial Results
Complete financial analysis of Golden Ally Lifetech Group, Inc. (AQPW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Golden Ally Lifetech Group, Inc., a leading company in the Beverages – Non-Alcoholic industry within the Consumer Defensive sector.
- Qingdao Daneng Environmental Protection Equipment Co., Ltd. (688501.SS) Income Statement Analysis – Financial Results
- 5740 (SMC) Income Statement Analysis – Financial Results
- Nordea Invest Global Small Cap (NDIGSCKL1.CO) Income Statement Analysis – Financial Results
- Kimbell Royalty Partners, LP (KRP) Income Statement Analysis – Financial Results
- Radius Residential Care Limited (RAD.NZ) Income Statement Analysis – Financial Results
Golden Ally Lifetech Group, Inc. (AQPW)
Industry: Beverages - Non-Alcoholic
Sector: Consumer Defensive
About Golden Ally Lifetech Group, Inc.
Golden Ally Lifetech Group, Inc., a development stage company, focuses on developing advanced technologies, energy solutions, and medical devices. It focuses on development of bioscience and sport medicines, including Sterilal self-sanitizing devices, PASS smart denture mouth guards, handheld heart attack sensors, and melanoma detection systems. The company also offers InCharge magnetic-based battery device that provides energy; and develops applications for de-icing application of graphene for use in the airline industry. The company was formerly known as Signet International Holdings, Inc. and changed its name to Golden Ally Lifetech Group, Inc. in July 2022. Golden Ally Lifetech Group, Inc. was incorporated in 2003 and is based in Austin, Texas.
| Metric | 2022 | 2021 | 2020 | 2019 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 40.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -40.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 98.45K | 0.00 | 6.00 | 6.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.21M | 188.96K | 354.78K | 114.03K | 361.79K | 389.91K | 431.03K | 314.89K | 380.04K | 296.16K | 310.63K | 124.05K | 411.44K | 0.00 |
| Selling & Marketing | 1.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 183.00K | 105.38K | 0.00 |
| SG&A | 5.97M | 188.96K | 354.78K | 114.03K | 361.79K | 389.91K | 431.03K | 314.89K | 380.04K | 296.16K | 310.63K | 307.05K | 516.82K | 170.77K |
| Other Expenses | 0.00 | 14.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.07M | 188.96K | 354.78K | 114.03K | 361.79K | 389.91K | 431.03K | 314.89K | 380.04K | 296.16K | 310.63K | 307.05K | 516.82K | 170.77K |
| Cost & Expenses | 6.07M | 188.96K | 354.78K | 114.03K | 361.79K | 389.91K | 431.03K | 314.89K | 380.04K | 296.16K | 310.63K | 307.05K | 516.82K | 170.77K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 500.00 | 150.00 | 0.00 | 0.00 | 4.44K | 4.56K |
| Depreciation & Amortization | 40.31K | 236.56K | 206.30K | 725.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 56.43K |
| EBITDA | -6.03M | -57.57K | -354.78K | -113.30K | -361.79K | -389.91K | -431.03K | -314.89K | -380.04K | -296.16K | -310.63K | -307.05K | -516.82K | -170.77K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -6.07M | -188.96K | -354.78K | -114.03K | -361.79K | -389.91K | -431.03K | -314.89K | -380.04K | -296.16K | -310.63K | -307.05K | -516.82K | -170.77K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | -725.00 | 0.00 | 0.00 | 0.00 | 0.00 | -500.00 | -150.00 | 0.00 | 0.00 | -4.44K | -60.99K |
| Income Before Tax | -6.07M | -174.91K | -354.78K | -114.75K | -361.79K | -389.91K | -431.03K | -314.89K | -380.54K | -296.31K | -310.63K | -307.05K | -521.25K | -231.77K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -57.57 | -351.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.56K |
| Net Income | -6.07M | -174.91K | -354.78K | -114.75K | -361.79K | -389.91K | -431.03K | -314.89K | -380.54K | -296.31K | -310.63K | -307.05K | -521.25K | -231.77K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | -0.02 | -0.01 | -0.03 | -0.04 | -0.05 | -0.05 | -0.07 | -0.06 | -0.07 | -0.07 | -0.13 | -0.07 |
| EPS Diluted | 0.00 | 0.00 | -0.02 | -0.01 | -0.03 | -0.04 | -0.05 | -0.05 | -0.07 | -0.06 | -0.07 | -0.07 | -0.13 | -0.07 |
| Weighted Avg Shares Out | 8.49B | 9.48B | 19.16M | 13.39M | 10.40M | 9.04M | 8.20M | 6.40M | 5.25M | 4.77M | 4.57M | 4.37M | 3.99M | 3.55M |
| Weighted Avg Shares Out (Dil) | 8.49B | 9.48B | 19.16M | 13.39M | 10.40M | 9.04M | 8.20M | 6.40M | 5.25M | 4.77M | 4.57M | 4.37M | 3.99M | 3.55M |
Source: https://incomestatements.info
Category: Stock Reports